Venus Concept Inc. (NASDAQ:VERO – Get Free Report) was the recipient of a significant decrease in short interest in the month of November. As of November 15th, there was short interest totalling 108,600 shares, a decrease of 92.5% from the October 31st total of 1,450,000 shares. Currently, 2.6% of the shares of the company are sold short. Based on an average daily volume of 1,780,000 shares, the days-to-cover ratio is currently 0.1 days.
Venus Concept Stock Down 0.6 %
NASDAQ:VERO traded down $0.00 during mid-day trading on Wednesday, hitting $0.34. 33,956 shares of the company’s stock traded hands, compared to its average volume of 1,095,525. Venus Concept has a 12 month low of $0.28 and a 12 month high of $2.22. The firm has a 50 day moving average of $0.46 and a two-hundred day moving average of $0.58. The company has a debt-to-equity ratio of 2.83, a current ratio of 1.86 and a quick ratio of 1.18.
Insiders Place Their Bets
In other Venus Concept news, major shareholder Michael Willingham Masters sold 71,368 shares of the company’s stock in a transaction dated Monday, September 30th. The shares were sold at an average price of $0.64, for a total transaction of $45,675.52. Following the completion of the sale, the insider now directly owns 22,383 shares in the company, valued at $14,325.12. This represents a 76.13 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Company insiders own 57.98% of the company’s stock.
Hedge Funds Weigh In On Venus Concept
Venus Concept Company Profile
Venus Concept Inc, a medical technology company, develops, commercializes, and delivers minimally invasive and non-invasive medical aesthetic and hair restoration technologies, and related services in the United States and internationally. Its product portfolio includes Venus Legacy, a noninvasive device used in dermatological and general surgical procedures for females; Venus Versa, a multi-application device used in aesthetic and cosmetic procedures; Venus Versa Pro; and Venus Viva and Venus Viva MD, an advanced, portable, and fractional RF system for dermatological procedures requiring ablation and resurfacing of the skin.
See Also
- Five stocks we like better than Venus Concept
- What is a Special Dividend?
- Microsoft Stock Gets a $550 Price Target: Time to Get Excited
- Market Cap Calculator: How to Calculate Market Cap
- Trump Tariffs in Focus: 2 Chinese Stocks to Own and 2 to Avoid
- How to Plot Fibonacci Price Inflection Levels
- 2 Generic Drug Stocks Ready to Surge in 2025
Receive News & Ratings for Venus Concept Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Venus Concept and related companies with MarketBeat.com's FREE daily email newsletter.